|
End-of-day quote
Shanghai S.E.
13/11/2026
|
5-day change | 1st Jan Change | ||
| 20.45 CNY | +0.89% |
|
-4.84% | +16.06% |
Chart calendar DaShenLin Pharmaceutical Group Co., Ltd.
Upcoming events on DaShenLin Pharmaceutical Group Co., Ltd.
| Today | Extraordinary General Meeting | 02:00 |
Past events on DaShenLin Pharmaceutical Group Co., Ltd.
| 30/10/2026 | Earnings release - Q3 2026 | |
| 30/09/2026 | Earnings presentation | 09:00 |
| 11/09/2026 | Extraordinary General Meeting | 03:00 |
| 25/08/2026 | Earnings release - Q2 2026 | |
| 18/05/2026 | Earnings presentation | 09:00 |
| 18/05/2026 | Annual General Meeting | 02:00 |
| 24/04/2026 | Earnings release - Annual 2025 | |
| 24/04/2026 | Earnings release - Q1 2026 | |
| 30/03/2026 | Extraordinary General Meeting | 03:00 |
| 09/12/2025 | Earnings presentation | 08:00 |
| 21/11/2025 | Extraordinary General Meeting | 02:00 |
Past dividends on DaShenLin Pharmaceutical Group Co., Ltd.
| 19/10/2026 | Ex-dividend date - 0.41 CNY | 05:00 |
| 26/06/2026 | Ex-dividend date - 0.49 CNY | 05:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 24 531 24 720 -0.76% | 26 497 26 779 -1.05% | 27 502 27 576 -0.27% | 29 567 | 32 519 | 35 836 |
|
EBITDA Million CNY | Released Forecast Spread | 2 119 2 532 -16.31% | 3 395 3 349 1.4% | 3 833 3 281 16.84% | 3 556 | 4 077 | 4 531 |
|
EBIT Million CNY | Released Forecast Spread | 1 632 1 868 -12.66% | 1 501 1 673 -10.32% | 2 038 1 881 8.36% | 2 410 | 2 645 | 3 008 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 1 628 1 807 -9.91% | 1 340 1 496 -10.42% | 1 849 1 702 8.66% | 2 239 | 2 549 | 2 906 |
|
Net income Million CNY | Released Forecast Spread | 1 166 1 303 -10.51% | 915 1 152 -20.57% | 1 235 1 186 4.15% | 1 510 | 1 721 | 1 950 |
|
EPS CNY | Released Forecast Spread | 1,03 1,15 -10.59% | 0,81 1,05 -23.07% | 1,08 1,04 4.26% | 1,33 | 1,50 | 1,70 |
| Announcement Date | 28/04/24 | 25/04/25 | 23/04/26 | - |
Quarterly results
| Fiscal Period | September | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 6 956 7 159 -2.84% | 6 567 7 200 -8.79% | 6 546 6 554 -0.12% | 7 434 7 262 2.37% | 6 973 7 184 -2.93% | 7 018 7 281 -3.62% | 7 317 7 336 -0.25% | 8 185 | 8 053 | 7 669 | 7 990 | |
|
EBITDA Million CNY | Released Forecast Spread | 827 | 882 | 791 | 682 | 1 066 | 996 | 939 | 827 | ||||
|
EBIT Million CNY | Released Forecast Spread | 650 | 476 403 18% | 410 330 24.26% | 502 226 122.08% | 710 692 2.64% | 616 568 8.48% | 472 575 -17.9% | 503 | 661 | 635 | 701 | |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 649 362 79.29% | 474 404 17.44% | 398 314 26.73% | 327 215 52.58% | 707 670 5.55% | 616 598 3.13% | 472 535 -11.75% | 421 | ||||
|
Net income Million CNY | Released Forecast Spread | 460 255 80.19% | 338 276 22.59% | 283 192 47% | 154 130 18.36% | 511 521 -1.87% | 416 423 -1.7% | 344 363 -5.31% | 224 | ||||
|
EPS CNY | Released Forecast Spread | 0,40 0,31 29.85% | 0,30 0,24 22.92% | 0,25 0,18 39.3% | 0,13 0,08 59.55% | 0,45 0,44 3.26% | 0,36 0,34 6.8% | 0,31 0,34 -8.75% | 0,20 | 0,38 | 0,34 | 0,33 | 0,56 |
| Announcement Date | 25/04/25 | 28/08/25 | 29/10/25 | 23/04/26 | 23/04/26 | 24/08/26 | 29/10/26 | - | - | - | - | - |
| Today | Extraordinary General Meeting | 06:45 | |
| 18/11/2026 | Ex-dividend date - 0.25622 ZAR | 05:00 | |
| 23/11/2026 | Extraordinary General Meeting | 02:30 | |
| 24/11/2026 | Earnings release - Q2 2027 | ||
| 30/11/2026 | Earnings release - Q3 2026 | ||
| 11/12/2026 | Extraordinary General Meeting | 09:30 | |
| 17/12/2026 | Ex-dividend date - 6.5 JPY | 05:00 | |
| 21/12/2026 | Sales and Revenue Release - Q3 2026 | ||
| 11/01/2027 | Sales and Revenue Release - Annual 2026 | ||
| 19/01/2027 | Sales and Revenue Release - Annual 2026 |
Past sector events for DaShenLin Pharmaceutical Group Co., Ltd.
| 13/11/2026 | Board of Directors Meeting | ||
| 13/11/2026 | Earnings release - Q2 2027 | P | |
| 12/11/2026 | Ex-dividend date - 0.068 EUR | 05:00 | |
| 12/11/2026 | Analyst/Investor Day | ||
| 11/11/2026 | Ex-dividend date - 0.63 SAR | 05:00 | |
| 06/11/2026 | Board of Directors Meeting | ||
| 05/11/2026 | Earnings presentation | 21:30 | |
| 05/11/2026 | Earnings release - Q3 2026 | ||
| 05/11/2026 | Earnings release - Q3 2026 | ||
| 05/11/2026 | Earnings presentation | 08:30 |
Quarterly revenue - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 603233 Stock
- Calendar DaShenLin Pharmaceutical Group Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
















